Homotypic Cell to Cell Cross-talk Among Human Natural Killer Cells Reveals Differential and Overlapping Roles of 2B4 and CD2
Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodie...
Saved in:
Published in | The Journal of biological chemistry Vol. 285; no. 53; pp. 41755 - 41764 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
31.12.2010
American Society for Biochemistry and Molecular Biology |
Subjects | |
Online Access | Get full text |
ISSN | 0021-9258 1083-351X 1083-351X |
DOI | 10.1074/jbc.M110.137976 |
Cover
Abstract | Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells. |
---|---|
AbstractList | Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells. Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)- gamma secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells. Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells. |
Author | Kim, Eun-Ok Kim, Nayoung Kim, Tae-Jin Lee, Kyung-Mi Kim, Sung Tae Kumar, Vinay |
Author_xml | – sequence: 1 givenname: Eun-Ok surname: Kim fullname: Kim, Eun-Ok organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea – sequence: 2 givenname: Tae-Jin surname: Kim fullname: Kim, Tae-Jin organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea – sequence: 3 givenname: Nayoung surname: Kim fullname: Kim, Nayoung organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea – sequence: 4 givenname: Sung Tae surname: Kim fullname: Kim, Sung Tae organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea – sequence: 5 givenname: Vinay surname: Kumar fullname: Kumar, Vinay organization: Department of Pathology, University of Chicago, Chicago, Illinois 60637 – sequence: 6 givenname: Kyung-Mi surname: Lee fullname: Lee, Kyung-Mi email: kyunglee@korea.ac.kr organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20813844$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUlFr1TAYDTJxd9Nn3yRvPnVLmrRNXoTZqVecDoaCbyFNv87MtqlJemHgjze93USFYV4O4TvncD6-c4QORjcCQs8pOaGk4qc3jTn5SJcfq2RVPkIbSgTLWEG_HqANITnNZF6IQ3QUwg1Jj0v6BB3mRFAmON-gn1s3uHg7WYNr6Hsc3Yq1dyFkUfff8dngxmu8nQc94k86zl73-IPte_B7asBXsAOd8Nx2HXgYo00MPbb4cge-19Nkk_7K9RCw63D-mu-H9Xn-FD3ukhCe3eEx-vL2zed6m11cvntfn11khlc8ZrJoTac7XgJviwYKbgrWcWm4KYkxUJqmolXFRElNA8JIKDRrytaIllIhaceO0avVd5qbAVqTIqYl1OTtoP2tctqqvyej_aau3U4xQqQkLBm8vDPw7scMIarBBpOW1yO4OShRcSpImUL8l5lTLgTde774M9TvNPe3SYRiJZjlFh46ZWzU0bolo-0VJWrpgEodUEsH1NqBpDv9R3dv_bBCrgpIR9hZ8CoYC6OB1nowUbXOPqj9BVKdyCU |
CitedBy_id | crossref_primary_10_1016_j_mrrev_2014_10_002 crossref_primary_10_4049_jimmunol_1701240 crossref_primary_10_3389_fimmu_2018_02809 crossref_primary_10_1002_eji_201847931 crossref_primary_10_1016_j_jcyt_2023_07_002 crossref_primary_10_3389_fimmu_2023_1174138 crossref_primary_10_1002_eji_201343724 crossref_primary_10_1016_j_jprot_2013_06_024 crossref_primary_10_1371_journal_pone_0047664 crossref_primary_10_1016_j_jaci_2019_07_038 crossref_primary_10_1093_jrr_rrs037 crossref_primary_10_3390_ijms25031556 crossref_primary_10_3389_fimmu_2019_00879 crossref_primary_10_1002_eji_201646492 crossref_primary_10_3389_fimmu_2020_568927 crossref_primary_10_1111_imr_12021 crossref_primary_10_1371_journal_pone_0097844 crossref_primary_10_1038_s41598_024_52606_2 crossref_primary_10_1186_s13027_015_0043_8 crossref_primary_10_1016_j_cyto_2017_02_005 crossref_primary_10_18632_oncotarget_13660 |
Cites_doi | 10.4049/jimmunol.162.12.6981 10.1152/ajpgi.90497.2008 10.1182/blood-2009-08-238469 10.4049/jimmunol.180.12.8159 10.1093/intimm/dxh358 10.1016/j.imlet.2006.02.006 10.4049/jimmunol.148.7.2023 10.1073/pnas.0604236103 10.4049/jimmunol.179.12.8009 10.1084/jem.20031989 10.4049/jimmunol.175.7.4226 10.1002/eji.200636341 10.4049/jimmunol.175.4.2045 10.1016/j.molimm.2008.03.021 10.1084/jem.178.4.1397 10.4049/jimmunol.167.12.6706 10.1073/pnas.92.15.6728 10.1084/jem.190.10.1383 10.1016/j.molimm.2004.07.032 10.1016/j.jim.2004.08.008 10.1111/j.1600-065X.2006.00453.x 10.1016/S0301-472X(00)00652-4 10.3858/emm.2009.41.3.019 10.4049/jimmunol.0901572 10.1182/blood-2004-08-3269 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y 10.4049/jimmunol.173.1.174 10.1182/blood-2009-01-201632 10.1084/jem.188.11.2083 10.1182/blood-2002-07-2206 10.1083/jcb.200809136 10.1074/jbc.M807053200 10.1182/blood-2004-09-3796 10.1016/j.molimm.2004.07.021 10.4049/jimmunol.176.8.4646 10.1182/blood-2005-01-0185 10.1002/eji.200838733 10.1038/317428a0 10.4049/jimmunol.167.11.6210 10.1093/intimm/dxl141 10.4049/jimmunol.174.2.800 10.1182/blood-2007-02-076927 |
ContentType | Journal Article |
Copyright | 2010 © 2010 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. 2010 by The American Society for Biochemistry and Molecular Biology, Inc. |
Copyright_xml | – notice: 2010 © 2010 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. – notice: 2010 by The American Society for Biochemistry and Molecular Biology, Inc. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 5PM |
DOI | 10.1074/jbc.M110.137976 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
DocumentTitleAlternate | Cell to Cell Cross-talk through 2B4 and CD2 |
EISSN | 1083-351X |
EndPage | 41764 |
ExternalDocumentID | PMC3009903 20813844 10_1074_jbc_M110_137976 S0021925819761614 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -DZ -ET -~X 0SF 18M 29J 2WC 34G 39C 4.4 53G 5BI 5GY 5RE 5VS 6I. 79B 85S AAEDW AAFTH AAFWJ AARDX AAXUO ABDNZ ABOCM ABPPZ ABRJW ACGFO ACNCT ADBBV ADIYS ADNWM AENEX AEXQZ AFFNX AFOSN AFPKN ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BTFSW C1A CJ0 CS3 DIK DU5 E3Z EBS EJD F5P FDB FRP GROUPED_DOAJ GX1 HH5 HYE IH2 KQ8 L7B N9A OK1 P-O P0W P2P R.V RHF RHI RNS ROL RPM SJN TBC TN5 TR2 UHB UKR UPT VQA W8F WH7 WOQ XFK XSW YQT YSK YWH YZZ ZA5 ZE2 ~02 ~KM .55 .7T .GJ 0R~ 186 3O- 41~ 6TJ AALRI AAYJJ AAYOK AAYWO AAYXX ABFSI ACSFO ACVFH ACYGS ADCNI ADVLN ADXHL AEUPX AFPUW AI. AIGII AITUG AKBMS AKRWK AKYEP CITATION E.L FA8 H13 J5H MVM NHB OHT QZG UQL VH1 WHG X7M XJT Y6R YYP ZGI ZY4 CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 5PM |
ID | FETCH-LOGICAL-c474t-95dcfaf46e4d5be54c53f49c4c60cce6cb71773861cbe8c9e5a3b6dc8d11891f3 |
ISSN | 0021-9258 1083-351X |
IngestDate | Thu Aug 21 18:14:01 EDT 2025 Fri Sep 05 09:10:08 EDT 2025 Fri Sep 05 06:24:13 EDT 2025 Wed Mar 19 04:48:45 EDT 2025 Thu Apr 24 23:06:53 EDT 2025 Tue Jul 01 01:53:45 EDT 2025 Fri Feb 23 02:45:46 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 53 |
Keywords | CD2 Receptors Immunology 2B4 Cell-Cell Interaction Innate Immunity NK Cells CD48 Cellular Immune Response CD58 |
Language | English |
License | This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0 https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c474t-95dcfaf46e4d5be54c53f49c4c60cce6cb71773861cbe8c9e5a3b6dc8d11891f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 Supported by Seoul R&BD Program Grant 10920. Supported by the National Nuclear R&D program grant BAERI. Both authors contributed equally to this paper. Supported by Innovative Research Institute for Cell Therapy Grant A062260. |
OpenAccessLink | https://dx.doi.org/10.1074/jbc.M110.137976 |
PMID | 20813844 |
PQID | 821488103 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3009903 proquest_miscellaneous_874180677 proquest_miscellaneous_821488103 pubmed_primary_20813844 crossref_citationtrail_10_1074_jbc_M110_137976 crossref_primary_10_1074_jbc_M110_137976 elsevier_sciencedirect_doi_10_1074_jbc_M110_137976 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-12-31 |
PublicationDateYYYYMMDD | 2010-12-31 |
PublicationDate_xml | – month: 12 year: 2010 text: 2010-12-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 9650 Rockville Pike, Bethesda, MD 20814, U.S.A |
PublicationTitle | The Journal of biological chemistry |
PublicationTitleAlternate | J Biol Chem |
PublicationYear | 2010 |
Publisher | Elsevier Inc American Society for Biochemistry and Molecular Biology |
Publisher_xml | – name: Elsevier Inc – name: American Society for Biochemistry and Molecular Biology |
References | Siliciano, Pratt, Schmidt, Ritz, Reinherz (bib33) 1985; 317 Wahle, Paraiso, Kendig, Lawrence, Chen, Wu, Kerr (bib38) 2007; 179 Bryceson, Ljunggren, Long (bib29) 2009; 114 Mathew, Rao, Kim, Bambard, Mathew (bib20) 2009; 39 Assarsson, Kambayashi, Persson, Ljunggren, Chambers (bib8) 2005; 42 Messmer, Eissmann, Stark, Watzl (bib22) 2006; 176 Veillette (bib2) 2006; 214 Crawford, Stark, Kitchens, Sternheim, Pantazopoulos, Triantafellow, Wang, Vasir, Larsen, Gabuzda, Reinherz, Alper (bib30) 2003; 102 Assarsson, Kambayashi, Persson, Chambers, Ljunggren (bib9) 2005; 175 Espagnolle, Depoil, Zaru, Demeur, Champagne, Guiraud, Valitutti (bib31) 2007; 19 Nakajima, Cella, Langen, Friedlein, Colonna (bib14) 1999; 29 Mahajan, Gollob, Ritz, Frank (bib4) 2001; 29 Kaizuka, Douglass, Vardhana, Dustin, Vale (bib35) 2009; 185 Kanner, Damle, Blake, Aruffo, Ledbetter (bib34) 1992; 148 Stark, Watzl (bib19) 2006; 18 Betser-Cohen, Mizrahi, Elboim, Alsheich-Bartok, Mandelboim (bib27) 2010; 184 Saborit-Villarroya, Martinez-Barriocanal, Oliver-Vila, Engel, Sayos, Martin (bib40) 2008; 45 Saborit-Villarroya, Del Valle, Romero, Esplugues, Lauzurica, Engel, Martín (bib24) 2005; 175 Bachmann, Barner, Kopf (bib32) 1999; 190 Brown, Boles, van der Merwe, Kumar, Mathew, Barclay (bib6) 1998; 188 Tangye, Lazetic, Woollatt, Sutherland, Lanier, Phillips (bib13) 1999; 162 Chen, Allan, Krzewski, Ge, Kopcow, Strominger (bib25) 2006; 103 Vaidya, Stepp, McNerney, Lee, Bennett, Lee, Stewart, Kumar, Mathew (bib3) 2005; 174 Lee, Forman, McNerney, Stepp, Kuppireddi, Guzior, Latchman, Sayegh, Yagita, Park, Oh, Wülfing, Schatzle, Mathew, Sharpe, Kumar (bib7) 2006; 107 Endt, Eissmann, Hoffmann, Meinke, Giese, Watzl (bib41) 2007; 37 Yoon, Yun, Park, Won, Kim, Sohn, Cho, Kim (bib18) 2009; 41 Vaidya, Mathew (bib21) 2006; 105 Assarsson, Kambayashi, Schatzle, Cramer, von Bonin, Jensen, Ljunggren, Chambers (bib11) 2004; 173 Valiante, Trinchieri (bib5) 1993; 178 Lee, McNerney, Stepp, Mathew, Schatzle, Bennett, Kumar (bib12) 2004; 199 Fauriat, Long, Ljunggren, Bryceson (bib28) 2010; 115 Taniguchi, Guzior, Kumar (bib26) 2007; 110 Chlewicki, Velikovsky, Balakrishnan, Mariuzza, Kumar (bib42) 2008; 180 Alter, Malenfant, Altfeld (bib17) 2004; 294 McNerney, Lee, Kumar (bib1) 2005; 42 Zheng, Wang, Wei, Sun, Tian (bib37) 2009; 284 Sadelain, Wang, Antoniou, Grosveld, Mulligan (bib16) 1995; 92 Ebert, Panja, Praveen (bib36) 2009; 296 Dupré, Andolfi, Tangye, Clementi, Locatelli, Aricò, Aiuti, Roncarolo (bib15) 2005; 105 Chuang, Kumaresan, Mathew (bib23) 2001; 167 Kambayashi, Assarsson, Chambers, Ljunggren (bib10) 2001; 167 Eissmann, Beauchamp, Wooters, Tilton, Long, Watzl (bib39) 2005; 105 Dupré (10.1074/jbc.M110.137976_bib15) 2005; 105 Eissmann (10.1074/jbc.M110.137976_bib39) 2005; 105 Tangye (10.1074/jbc.M110.137976_bib13) 1999; 162 Lee (10.1074/jbc.M110.137976_bib7) 2006; 107 Crawford (10.1074/jbc.M110.137976_bib30) 2003; 102 Chen (10.1074/jbc.M110.137976_bib25) 2006; 103 Veillette (10.1074/jbc.M110.137976_bib2) 2006; 214 Chlewicki (10.1074/jbc.M110.137976_bib42) 2008; 180 Assarsson (10.1074/jbc.M110.137976_bib9) 2005; 175 Assarsson (10.1074/jbc.M110.137976_bib8) 2005; 42 Yoon (10.1074/jbc.M110.137976_bib18) 2009; 41 Betser-Cohen (10.1074/jbc.M110.137976_bib27) 2010; 184 McNerney (10.1074/jbc.M110.137976_bib1) 2005; 42 Bachmann (10.1074/jbc.M110.137976_bib32) 1999; 190 Kaizuka (10.1074/jbc.M110.137976_bib35) 2009; 185 Alter (10.1074/jbc.M110.137976_bib17) 2004; 294 Lee (10.1074/jbc.M110.137976_bib12) 2004; 199 Wahle (10.1074/jbc.M110.137976_bib38) 2007; 179 Vaidya (10.1074/jbc.M110.137976_bib3) 2005; 174 Fauriat (10.1074/jbc.M110.137976_bib28) 2010; 115 Saborit-Villarroya (10.1074/jbc.M110.137976_bib40) 2008; 45 Ebert (10.1074/jbc.M110.137976_bib36) 2009; 296 Mathew (10.1074/jbc.M110.137976_bib20) 2009; 39 Sadelain (10.1074/jbc.M110.137976_bib16) 1995; 92 Zheng (10.1074/jbc.M110.137976_bib37) 2009; 284 Siliciano (10.1074/jbc.M110.137976_bib33) 1985; 317 Messmer (10.1074/jbc.M110.137976_bib22) 2006; 176 Bryceson (10.1074/jbc.M110.137976_bib29) 2009; 114 Assarsson (10.1074/jbc.M110.137976_bib11) 2004; 173 Nakajima (10.1074/jbc.M110.137976_bib14) 1999; 29 Stark (10.1074/jbc.M110.137976_bib19) 2006; 18 Kambayashi (10.1074/jbc.M110.137976_bib10) 2001; 167 Brown (10.1074/jbc.M110.137976_bib6) 1998; 188 Endt (10.1074/jbc.M110.137976_bib41) 2007; 37 Saborit-Villarroya (10.1074/jbc.M110.137976_bib24) 2005; 175 Vaidya (10.1074/jbc.M110.137976_bib21) 2006; 105 Taniguchi (10.1074/jbc.M110.137976_bib26) 2007; 110 Espagnolle (10.1074/jbc.M110.137976_bib31) 2007; 19 Mahajan (10.1074/jbc.M110.137976_bib4) 2001; 29 Kanner (10.1074/jbc.M110.137976_bib34) 1992; 148 Valiante (10.1074/jbc.M110.137976_bib5) 1993; 178 Chuang (10.1074/jbc.M110.137976_bib23) 2001; 167 |
References_xml | – volume: 103 start-page: 10346 year: 2006 end-page: 10351 ident: bib25 publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 110 start-page: 2020 year: 2007 end-page: 2023 ident: bib26 publication-title: Blood. – volume: 41 start-page: 161 year: 2009 end-page: 170 ident: bib18 publication-title: Exp. Mol. Med. – volume: 167 start-page: 6210 year: 2001 end-page: 6216 ident: bib23 publication-title: J. Immunol. – volume: 284 start-page: 21280 year: 2009 end-page: 21287 ident: bib37 publication-title: J. Biol. Chem. – volume: 105 start-page: 4383 year: 2005 end-page: 4389 ident: bib15 publication-title: Blood. – volume: 19 start-page: 239 year: 2007 end-page: 248 ident: bib31 publication-title: Int. Immunol. – volume: 188 start-page: 2083 year: 1998 end-page: 2090 ident: bib6 publication-title: J. Exp. Med. – volume: 45 start-page: 3446 year: 2008 end-page: 3453 ident: bib40 publication-title: Mol. Immunol. – volume: 178 start-page: 1397 year: 1993 end-page: 1406 ident: bib5 publication-title: J. Exp. Med. – volume: 18 start-page: 241 year: 2006 end-page: 247 ident: bib19 publication-title: Int. Immunol. – volume: 180 start-page: 8159 year: 2008 end-page: 8167 ident: bib42 publication-title: J. Immunol. – volume: 105 start-page: 4722 year: 2005 end-page: 4729 ident: bib39 publication-title: Blood. – volume: 175 start-page: 4226 year: 2005 end-page: 4235 ident: bib24 publication-title: J. Immunol. – volume: 39 start-page: 1632 year: 2009 end-page: 1641 ident: bib20 publication-title: Eur. J. Immunol. – volume: 42 start-page: 489 year: 2005 end-page: 494 ident: bib1 publication-title: Mol. Immunol. – volume: 294 start-page: 15 year: 2004 end-page: 22 ident: bib17 publication-title: J. Immunol. Methods. – volume: 176 start-page: 4646 year: 2006 end-page: 4650 ident: bib22 publication-title: J. Immunol. – volume: 317 start-page: 428 year: 1985 end-page: 430 ident: bib33 publication-title: Nature. – volume: 148 start-page: 2023 year: 1992 end-page: 2029 ident: bib34 publication-title: J. Immunol. – volume: 173 start-page: 174 year: 2004 end-page: 180 ident: bib11 publication-title: J. Immunol. – volume: 105 start-page: 180 year: 2006 end-page: 184 ident: bib21 publication-title: Immunol. Lett. – volume: 184 start-page: 2761 year: 2010 end-page: 2768 ident: bib27 publication-title: J. Immunol. – volume: 179 start-page: 8009 year: 2007 end-page: 8015 ident: bib38 publication-title: J. Immunol. – volume: 42 start-page: 419 year: 2005 end-page: 423 ident: bib8 publication-title: Mol. Immunol. – volume: 114 start-page: 2657 year: 2009 end-page: 2666 ident: bib29 publication-title: Blood. – volume: 29 start-page: 209 year: 2001 end-page: 220 ident: bib4 publication-title: Exp. Hematol. – volume: 167 start-page: 6706 year: 2001 end-page: 6710 ident: bib10 publication-title: J. Immunol. – volume: 115 start-page: 2167 year: 2010 end-page: 2176 ident: bib28 publication-title: Blood. – volume: 296 start-page: G671 year: 2009 end-page: G677 ident: bib36 publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 162 start-page: 6981 year: 1999 end-page: 6985 ident: bib13 publication-title: J. Immunol. – volume: 190 start-page: 1383 year: 1999 end-page: 1392 ident: bib32 publication-title: J. Exp. Med. – volume: 214 start-page: 22 year: 2006 end-page: 34 ident: bib2 publication-title: Immunol. Rev. – volume: 107 start-page: 3181 year: 2006 end-page: 3188 ident: bib7 publication-title: Blood. – volume: 175 start-page: 2045 year: 2005 end-page: 2049 ident: bib9 publication-title: J. Immunol. – volume: 199 start-page: 1245 year: 2004 end-page: 1254 ident: bib12 publication-title: J. Exp. Med. – volume: 174 start-page: 800 year: 2005 end-page: 807 ident: bib3 publication-title: J. Immunol. – volume: 37 start-page: 193 year: 2007 end-page: 198 ident: bib41 publication-title: Eur. J. Immunol. – volume: 185 start-page: 521 year: 2009 end-page: 534 ident: bib35 publication-title: J. Cell Biol. – volume: 29 start-page: 1676 year: 1999 end-page: 1683 ident: bib14 publication-title: Eur. J. Immunol. – volume: 92 start-page: 6728 year: 1995 end-page: 6732 ident: bib16 publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 102 start-page: 1745 year: 2003 end-page: 1752 ident: bib30 publication-title: Blood. – volume: 162 start-page: 6981 year: 1999 ident: 10.1074/jbc.M110.137976_bib13 publication-title: J. Immunol. doi: 10.4049/jimmunol.162.12.6981 – volume: 296 start-page: G671 year: 2009 ident: 10.1074/jbc.M110.137976_bib36 publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.90497.2008 – volume: 115 start-page: 2167 year: 2010 ident: 10.1074/jbc.M110.137976_bib28 publication-title: Blood. doi: 10.1182/blood-2009-08-238469 – volume: 180 start-page: 8159 year: 2008 ident: 10.1074/jbc.M110.137976_bib42 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.12.8159 – volume: 18 start-page: 241 year: 2006 ident: 10.1074/jbc.M110.137976_bib19 publication-title: Int. Immunol. doi: 10.1093/intimm/dxh358 – volume: 105 start-page: 180 year: 2006 ident: 10.1074/jbc.M110.137976_bib21 publication-title: Immunol. Lett. doi: 10.1016/j.imlet.2006.02.006 – volume: 148 start-page: 2023 year: 1992 ident: 10.1074/jbc.M110.137976_bib34 publication-title: J. Immunol. doi: 10.4049/jimmunol.148.7.2023 – volume: 103 start-page: 10346 year: 2006 ident: 10.1074/jbc.M110.137976_bib25 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0604236103 – volume: 179 start-page: 8009 year: 2007 ident: 10.1074/jbc.M110.137976_bib38 publication-title: J. Immunol. doi: 10.4049/jimmunol.179.12.8009 – volume: 199 start-page: 1245 year: 2004 ident: 10.1074/jbc.M110.137976_bib12 publication-title: J. Exp. Med. doi: 10.1084/jem.20031989 – volume: 175 start-page: 4226 year: 2005 ident: 10.1074/jbc.M110.137976_bib24 publication-title: J. Immunol. doi: 10.4049/jimmunol.175.7.4226 – volume: 37 start-page: 193 year: 2007 ident: 10.1074/jbc.M110.137976_bib41 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200636341 – volume: 175 start-page: 2045 year: 2005 ident: 10.1074/jbc.M110.137976_bib9 publication-title: J. Immunol. doi: 10.4049/jimmunol.175.4.2045 – volume: 45 start-page: 3446 year: 2008 ident: 10.1074/jbc.M110.137976_bib40 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2008.03.021 – volume: 178 start-page: 1397 year: 1993 ident: 10.1074/jbc.M110.137976_bib5 publication-title: J. Exp. Med. doi: 10.1084/jem.178.4.1397 – volume: 167 start-page: 6706 year: 2001 ident: 10.1074/jbc.M110.137976_bib10 publication-title: J. Immunol. doi: 10.4049/jimmunol.167.12.6706 – volume: 92 start-page: 6728 year: 1995 ident: 10.1074/jbc.M110.137976_bib16 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.92.15.6728 – volume: 190 start-page: 1383 year: 1999 ident: 10.1074/jbc.M110.137976_bib32 publication-title: J. Exp. Med. doi: 10.1084/jem.190.10.1383 – volume: 42 start-page: 489 year: 2005 ident: 10.1074/jbc.M110.137976_bib1 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2004.07.032 – volume: 294 start-page: 15 year: 2004 ident: 10.1074/jbc.M110.137976_bib17 publication-title: J. Immunol. Methods. doi: 10.1016/j.jim.2004.08.008 – volume: 214 start-page: 22 year: 2006 ident: 10.1074/jbc.M110.137976_bib2 publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2006.00453.x – volume: 29 start-page: 209 year: 2001 ident: 10.1074/jbc.M110.137976_bib4 publication-title: Exp. Hematol. doi: 10.1016/S0301-472X(00)00652-4 – volume: 41 start-page: 161 year: 2009 ident: 10.1074/jbc.M110.137976_bib18 publication-title: Exp. Mol. Med. doi: 10.3858/emm.2009.41.3.019 – volume: 184 start-page: 2761 year: 2010 ident: 10.1074/jbc.M110.137976_bib27 publication-title: J. Immunol. doi: 10.4049/jimmunol.0901572 – volume: 105 start-page: 4383 year: 2005 ident: 10.1074/jbc.M110.137976_bib15 publication-title: Blood. doi: 10.1182/blood-2004-08-3269 – volume: 29 start-page: 1676 year: 1999 ident: 10.1074/jbc.M110.137976_bib14 publication-title: Eur. J. Immunol. doi: 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y – volume: 173 start-page: 174 year: 2004 ident: 10.1074/jbc.M110.137976_bib11 publication-title: J. Immunol. doi: 10.4049/jimmunol.173.1.174 – volume: 114 start-page: 2657 year: 2009 ident: 10.1074/jbc.M110.137976_bib29 publication-title: Blood. doi: 10.1182/blood-2009-01-201632 – volume: 188 start-page: 2083 year: 1998 ident: 10.1074/jbc.M110.137976_bib6 publication-title: J. Exp. Med. doi: 10.1084/jem.188.11.2083 – volume: 102 start-page: 1745 year: 2003 ident: 10.1074/jbc.M110.137976_bib30 publication-title: Blood. doi: 10.1182/blood-2002-07-2206 – volume: 185 start-page: 521 year: 2009 ident: 10.1074/jbc.M110.137976_bib35 publication-title: J. Cell Biol. doi: 10.1083/jcb.200809136 – volume: 284 start-page: 21280 year: 2009 ident: 10.1074/jbc.M110.137976_bib37 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M807053200 – volume: 105 start-page: 4722 year: 2005 ident: 10.1074/jbc.M110.137976_bib39 publication-title: Blood. doi: 10.1182/blood-2004-09-3796 – volume: 42 start-page: 419 year: 2005 ident: 10.1074/jbc.M110.137976_bib8 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2004.07.021 – volume: 176 start-page: 4646 year: 2006 ident: 10.1074/jbc.M110.137976_bib22 publication-title: J. Immunol. doi: 10.4049/jimmunol.176.8.4646 – volume: 107 start-page: 3181 year: 2006 ident: 10.1074/jbc.M110.137976_bib7 publication-title: Blood. doi: 10.1182/blood-2005-01-0185 – volume: 39 start-page: 1632 year: 2009 ident: 10.1074/jbc.M110.137976_bib20 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200838733 – volume: 317 start-page: 428 year: 1985 ident: 10.1074/jbc.M110.137976_bib33 publication-title: Nature. doi: 10.1038/317428a0 – volume: 167 start-page: 6210 year: 2001 ident: 10.1074/jbc.M110.137976_bib23 publication-title: J. Immunol. doi: 10.4049/jimmunol.167.11.6210 – volume: 19 start-page: 239 year: 2007 ident: 10.1074/jbc.M110.137976_bib31 publication-title: Int. Immunol. doi: 10.1093/intimm/dxl141 – volume: 174 start-page: 800 year: 2005 ident: 10.1074/jbc.M110.137976_bib3 publication-title: J. Immunol. doi: 10.4049/jimmunol.174.2.800 – volume: 110 start-page: 2020 year: 2007 ident: 10.1074/jbc.M110.137976_bib26 publication-title: Blood. doi: 10.1182/blood-2007-02-076927 |
SSID | ssj0000491 |
Score | 2.1237214 |
Snippet | Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 41755 |
SubjectTerms | 2B4 Animals Antigens, CD - biosynthesis Antigens, CD - chemistry CD2 CD2 Antigens - chemistry CD48 CD48 Antigen CD58 CD58 Antigens - biosynthesis Cell Proliferation Cell-Cell Interaction Cellular Immune Response Humans Immunity, Innate Immunology Innate Immunity Interferon-gamma - metabolism Interleukin-2 - metabolism K562 Cells Killer Cells, Natural - metabolism Leukocytes, Mononuclear - cytology Lymphocyte Activation Mice NK Cells Receptors Receptors, Immunologic - chemistry Signaling Lymphocytic Activation Molecule Family |
Title | Homotypic Cell to Cell Cross-talk Among Human Natural Killer Cells Reveals Differential and Overlapping Roles of 2B4 and CD2 |
URI | https://dx.doi.org/10.1074/jbc.M110.137976 https://www.ncbi.nlm.nih.gov/pubmed/20813844 https://www.proquest.com/docview/821488103 https://www.proquest.com/docview/874180677 https://pubmed.ncbi.nlm.nih.gov/PMC3009903 |
Volume | 285 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FcoALgpZHeGkPCCEhl9i79trHEkBRUYsQqZSb5V2v1SiNE1EHKYg_wL9mZtZOXNMg4GJH-3CifJ_Hs96Zbxh7UWh4MAjjeypSuSdFEHs6l9LLhQpMEUtt6dXAyWk0OpPHk3DS6_1sRS2tKn1ovl-bV_I_qEIb4IpZsv-A7Oai0ACfAV84AsJw_CuMRxhKt15OzWt8_45uJJ3pyeeBVz2rawm5Qnyk4QmIzCj9j4binsE3iwrKTaGUalqLB2Bo50W2pHQqDEGkkI_graTO4bug7dVu88vIs3XCTk56pKknt93rn7v8mtL7NOs0jjPrHU_LTutptkaL1Gn9Ak04of3WwkWA1ObeOksLvh-mEUzapjhw5XtqzoWiZVkl-DnhtTYfnCC0-docnvhUyEMlrqRMiwHLOVEgAAdIxE5wsiOz3XTdYDcDpWjH_-PnrfA8LKT8RhlKyTedb0NJ6Xr-Lv_m9_VLNwy35deM77I7NWz8yLHrHuvZcp8dHAFZFvM1f8kpRJj2XvbZrWED5wH7sSEfRybxauHOW_JxIh8n8vGafNyRj4Ze8pp8vE0-DvziLfJxIh9fFBzIR51Avvvs7MP78XDk1aU8PCOVrLwkzE2RFTKyMg-1DaUJRSETI000MMZGRitfYf1Z32gbm8SGmdBRbuIcFsCJX4gHbK9clPYR47G2QZLjdjz4ziKMtSqK2OYiSwZWycz02WEDQGpqnXsst3KRUryFkimAlyJ4qQOvz15tJiydxMvuoUGDaFp7qM7zTIGMuyfxBvsUMMI_OCvtYnWZxoEPz09_IP4wBNWlUOWxzx46tmx-Y8O4PlNXeLQZgMrxV3vK6TkpyAtcGA7E453XfMJub-_ap2yv-rqyz8D7rvRzui9-AbbZ3S4 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Homotypic+cell+to+cell+cross-talk+among+human+natural+killer+cells+reveals+differential+and+overlapping+roles+of+2B4+and+CD2&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Kim%2C+Eun-Ok&rft.au=Kim%2C+Tae-Jin&rft.au=Kim%2C+Nayoung&rft.au=Kim%2C+Sung+Tae&rft.date=2010-12-31&rft.eissn=1083-351X&rft.volume=285&rft.issue=53&rft.spage=41755&rft_id=info:doi/10.1074%2Fjbc.M110.137976&rft_id=info%3Apmid%2F20813844&rft.externalDocID=20813844 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon |